The Molecular Pathogenesis of Osteosarcoma: A Review

Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60-70, with no significant improvements in prognosis since the advent of multiagent chemothera...

Full description

Bibliographic Details
Main Authors: Choong, P., Broadhead, M., Clark, J., Myers, D., Dass, Crispin
Format: Journal Article
Published: Hindawi Publishing Corporation 2011
Online Access:http://www.hindawi.com/journals/srcm/
http://hdl.handle.net/20.500.11937/57021
_version_ 1848759995976384512
author Choong, P.
Broadhead, M.
Clark, J.
Myers, D.
Dass, Crispin
author_facet Choong, P.
Broadhead, M.
Clark, J.
Myers, D.
Dass, Crispin
author_sort Choong, P.
building Curtin Institutional Repository
collection Online Access
description Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60-70, with no significant improvements in prognosis since the advent of multiagent chemotherapy. Diagnosis, staging, and surgical management of osteosarcoma remain focused on our anatomical understanding of the disease. As our knowledge of the molecular pathogenesis of osteosarcoma expands, potential therapeutic targets are being identified. A comprehensive understanding of these mechanisms is essential if we are to improve the prognosis of patients with osteosarcoma through tumour-targeted therapies. This paper will outline the pathogenic mechanisms of osteosarcoma oncogenesis and progression and will discuss some of the more frontline translational studies performed to date in search of novel, safer, and more targeted drugs for disease management.
first_indexed 2025-11-14T10:08:45Z
format Journal Article
id curtin-20.500.11937-57021
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:08:45Z
publishDate 2011
publisher Hindawi Publishing Corporation
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-570212017-10-02T03:52:02Z The Molecular Pathogenesis of Osteosarcoma: A Review Choong, P. Broadhead, M. Clark, J. Myers, D. Dass, Crispin Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60-70, with no significant improvements in prognosis since the advent of multiagent chemotherapy. Diagnosis, staging, and surgical management of osteosarcoma remain focused on our anatomical understanding of the disease. As our knowledge of the molecular pathogenesis of osteosarcoma expands, potential therapeutic targets are being identified. A comprehensive understanding of these mechanisms is essential if we are to improve the prognosis of patients with osteosarcoma through tumour-targeted therapies. This paper will outline the pathogenic mechanisms of osteosarcoma oncogenesis and progression and will discuss some of the more frontline translational studies performed to date in search of novel, safer, and more targeted drugs for disease management. 2011 Journal Article http://hdl.handle.net/20.500.11937/57021 10.1155/2011/959248 http://www.hindawi.com/journals/srcm/ http://creativecommons.org/licenses/by/4.0/ Hindawi Publishing Corporation fulltext
spellingShingle Choong, P.
Broadhead, M.
Clark, J.
Myers, D.
Dass, Crispin
The Molecular Pathogenesis of Osteosarcoma: A Review
title The Molecular Pathogenesis of Osteosarcoma: A Review
title_full The Molecular Pathogenesis of Osteosarcoma: A Review
title_fullStr The Molecular Pathogenesis of Osteosarcoma: A Review
title_full_unstemmed The Molecular Pathogenesis of Osteosarcoma: A Review
title_short The Molecular Pathogenesis of Osteosarcoma: A Review
title_sort molecular pathogenesis of osteosarcoma: a review
url http://www.hindawi.com/journals/srcm/
http://hdl.handle.net/20.500.11937/57021